{
  "id": [
    "30451318"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "30451318"
  ],
  "pmcid": [
    "PMC6587744"
  ],
  "doi": [
    "10.1111/pde.13723"
  ],
  "title": [
    "Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials."
  ],
  "authorString": [
    "Hebert AA, Glaser DA, Green L, Werschler WP, Forsha DW, Drew J, Gopalan R, Pariser DM."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Hebert AA"
          ],
          "firstName": [
            "Adelaide A"
          ],
          "lastName": [
            "Hebert"
          ],
          "initials": [
            "AA"
          ],
          "authorId": [
            {
              "_": "0000-0002-9167-5729",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "affiliation": [
            "UTHealth McGovern Medical School, Houston, Texas."
          ]
        },
        {
          "fullName": [
            "Glaser DA"
          ],
          "firstName": [
            "Dee Anna"
          ],
          "lastName": [
            "Glaser"
          ],
          "initials": [
            "DA"
          ],
          "affiliation": [
            "Saint Louis University, St. Louis, Missouri."
          ]
        },
        {
          "fullName": [
            "Green L"
          ],
          "firstName": [
            "Lawrence"
          ],
          "lastName": [
            "Green"
          ],
          "initials": [
            "L"
          ],
          "affiliation": [
            "George Washington University School of Medicine, Washington, District of Columbia."
          ]
        },
        {
          "fullName": [
            "Werschler WP"
          ],
          "firstName": [
            "William P"
          ],
          "lastName": [
            "Werschler"
          ],
          "initials": [
            "WP"
          ],
          "affiliation": [
            "Premier Clinical Research, Spokane, Washington."
          ]
        },
        {
          "fullName": [
            "Forsha DW"
          ],
          "firstName": [
            "Douglass W"
          ],
          "lastName": [
            "Forsha"
          ],
          "initials": [
            "DW"
          ],
          "affiliation": [
            "Jordan Valley Dermatology and Research Center, West Jordan, Utah."
          ]
        },
        {
          "fullName": [
            "Drew J"
          ],
          "firstName": [
            "Janice"
          ],
          "lastName": [
            "Drew"
          ],
          "initials": [
            "J"
          ],
          "affiliation": [
            "Dermira, Inc., Menlo Park, California."
          ]
        },
        {
          "fullName": [
            "Gopalan R"
          ],
          "firstName": [
            "Ramanan"
          ],
          "lastName": [
            "Gopalan"
          ],
          "initials": [
            "R"
          ],
          "affiliation": [
            "Dermira, Inc., Menlo Park, California."
          ]
        },
        {
          "fullName": [
            "Pariser DM"
          ],
          "firstName": [
            "David M"
          ],
          "lastName": [
            "Pariser"
          ],
          "initials": [
            "DM"
          ],
          "affiliation": [
            "Eastern Virginia Medical School and Virginia Clinical Research, Inc., Norfolk, Virginia."
          ]
        }
      ]
    }
  ],
  "authorIdList": [
    {
      "authorId": [
        {
          "_": "0000-0002-9167-5729",
          "$": {
            "type": "ORCID"
          }
        }
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "1"
      ],
      "volume": [
        "36"
      ],
      "journalIssueId": [
        "2773718"
      ],
      "dateOfPublication": [
        "2019 Jan"
      ],
      "monthOfPublication": [
        "1"
      ],
      "yearOfPublication": [
        "2019"
      ],
      "printPublicationDate": [
        "2019-01-01"
      ],
      "journal": [
        {
          "title": [
            "Pediatric dermatology"
          ],
          "ISOAbbreviation": [
            "Pediatr Dermatol"
          ],
          "medlineAbbreviation": [
            "Pediatr Dermatol"
          ],
          "NLMid": [
            "8406799"
          ],
          "ISSN": [
            "0736-8046"
          ],
          "ESSN": [
            "1525-1470"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2019"
  ],
  "pageInfo": [
    "89-99"
  ],
  "abstractText": [
    "OBJECTIVES:Hyperhidrosis in pediatric patients has been understudied. Post hoc analyses of two phase 3 randomized, vehicle-controlled, 4-week trials (ATMOS-1 [NCT02530281] and ATMOS-2 [NCT02530294]) were performed to assess efficacy and safety of topical anticholinergic glycopyrronium tosylate (GT) in pediatric patients. METHODS:Patients had primary axillary hyperhidrosis ≥ 6 months, average Axillary Sweating Daily Diary (ASDD/ASDD-Children [ASDD-C]) Item 2 (sweating severity) score ≥ 4, sweat production ≥ 50 mg/5 min (each axilla), and Hyperhidrosis Disease Severity Scale (HDSS) ≥ 3. Coprimary end points were ≥ 4-point improvement on ASDD/ASDD-C Item 2 (a validated patient-reported outcome) and change in gravimetrically measured sweat production at Week 4. Efficacy and safety data are shown through Week 4 for the pediatric (≥ 9 to ≤ 16 years) vs older (> 16 years) subgroups. RESULTS:Six hundred and ninety-seven patients were randomized in ATMOS-1/ATMOS-2 (GT, N = 463; vehicle, N = 234); 44 were ≥ 9 to ≤ 16 years (GT, n = 25; vehicle, n = 19). Baseline disease characteristics were generally similar across subgroups. GT-treated pediatric vs older patients had comparable improvements in ASDD/ASDD-C Item 2 (sweating severity) responder rate, HDSS responder rate (≥ 2-grade improvement]), sweat production, and quality of life (mean change from Baseline in Dermatology Life Quality Index [DLQI]/children's DLQI), with greater improvement vs vehicle. Treatment-emergent adverse events were similar between subgroups, and most were mild, transient, and infrequently led to discontinuation. CONCLUSIONS:Topical, once-daily GT improved disease severity (ASDD/ASDD-C, HDSS), sweat production, and quality of life (DLQI), with similar findings in children, adults, and the pooled population. GT was well tolerated, and treatment-emergent adverse events were qualitatively similar between subgroups and consistent with other anticholinergics."
  ],
  "affiliation": [
    "UTHealth McGovern Medical School, Houston, Texas."
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Print-Electronic"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "Clinical Trial, Phase III",
        "research-article",
        "Multicenter Study",
        "Randomized Controlled Trial",
        "Journal Article"
      ]
    }
  ],
  "grantsList": [
    {
      "grant": [
        {
          "agency": [
            "Dermira, Inc."
          ],
          "orderIn": [
            "0"
          ]
        }
      ]
    }
  ],
  "meshHeadingList": [
    {
      "meshHeading": [
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Axilla"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "PP"
                  ],
                  "qualifierName": [
                    "physiopathology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Humans"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Hyperhidrosis"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Glycopyrrolate"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AE"
                  ],
                  "qualifierName": [
                    "adverse effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Muscarinic Antagonists"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AE"
                  ],
                  "qualifierName": [
                    "adverse effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Treatment Outcome"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Administration, Topical"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Severity of Illness Index"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Quality of Life"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Adolescent"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Adult"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Aged"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Middle Aged"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Child"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "United States"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Germany"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Female"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Male"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Randomized Controlled Trials as Topic"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Young Adult"
          ]
        }
      ]
    }
  ],
  "chemicalList": [
    {
      "chemical": [
        {
          "name": [
            "Muscarinic Antagonists"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Glycopyrrolate"
          ],
          "registryNumber": [
            "V92SO9WP2I"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1111/pde.13723"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC6587744"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC6587744?pdf=render"
          ]
        }
      ]
    }
  ],
  "commentCorrectionList": [
    {
      "commentCorrection": [
        {
          "id": [
            "31099927"
          ],
          "source": [
            "MED"
          ],
          "reference": [
            "Pediatr Dermatol. 2019 May;36(3):424"
          ],
          "type": [
            "Erratum in"
          ],
          "orderIn": [
            "1"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "3"
  ],
  "hasData": [
    "N"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "license": [
    "cc by-nc-nd"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCompletion": [
    "2019-02-08"
  ],
  "dateOfCreation": [
    "2018-11-20"
  ],
  "firstIndexDate": [
    "2018-11-19"
  ],
  "fullTextReceivedDate": [
    "2019-07-05"
  ],
  "dateOfRevision": [
    "2019-07-03"
  ],
  "electronicPublicationDate": [
    "2018-11-19"
  ],
  "firstPublicationDate": [
    "2018-11-19"
  ]
}